Refine
Has Fulltext
- yes (124)
Is part of the Bibliography
- yes (124)
Year of publication
- 2021 (124) (remove)
Document Type
- Doctoral Thesis (123)
- Journal article (1)
Keywords
- Melanom (3)
- Angst (2)
- Angststörung (2)
- Arteriosklerose (2)
- Chlamydia trachomatis (2)
- Chromatin (2)
- DNA repair (2)
- Entzündung (2)
- Fluoreszenzmikroskopie (2)
- Fuchsbandwurm (2)
- Furcht (2)
- Furchtkonditionierung (2)
- G-Protein gekoppelte Rezeptoren (2)
- GPCR (2)
- Genetik (2)
- HUWE1 (2)
- Induzierte pluripotente Stammzelle (2)
- MAP-Kinase (2)
- MYC (2)
- MYCN (2)
- Maus (2)
- Mausmodell (2)
- Megakaryozyt (2)
- Multiple Sklerose (2)
- Multiples Myelom (2)
- Neisseria meningitidis (2)
- Neuroblastom (2)
- Neurodegeneration (2)
- Plasmozytom (2)
- Resistenz (2)
- Serotonin (2)
- Sphingolipide (2)
- Stammzelle (2)
- Thrombozyt (2)
- Tissue Engineering (2)
- Transcription (2)
- TrkB (2)
- Ubiquitin (2)
- Zellskelett (2)
- cAMP (2)
- cell wall (2)
- host-pathogen interaction (2)
- neuroblastoma (2)
- neuropathy (2)
- regulation (2)
- 177Lu-OPS201 (1)
- 3D models (1)
- 3D tissue model (1)
- 3D-Gewebemodell (1)
- 5`-UTR (1)
- 68Ga-OPS202 (1)
- 7T (1)
- ACC (1)
- ADGRL3 (1)
- ADHD (1)
- AI (1)
- ATF5 (1)
- ATGL (1)
- Acetylation (1)
- Acute myeloid leukemia (AML) (1)
- Adhesion GPCR (1)
- Adipose (1)
- Adipose-Derived Stromal/Stem Cells (1)
- Adrenalin (1)
- Adrenokortikales Karzinom (1)
- Advanced Therapy Medicinal Products (ATMP) (1)
- Adventitia (1)
- Agarose (1)
- Aiolos (1)
- Airway epithelia (1)
- Alzheimerkrankheit (1)
- Angstverhalten (1)
- Anthropocene (1)
- Anti-CD52-Antikörper (1)
- Antibody (1)
- Antigen CD44 (1)
- Antioxidantien (1)
- Aortenaneurysma (1)
- Arbeitsteilung (1)
- Arid biomes (1)
- Arrestine (1)
- Artesunate (1)
- Arzneimittel (1)
- Arzneimitteldesign (1)
- Arzneimittelzulassung (1)
- Aspergillus fumigatus (1)
- Atherosklerose (1)
- Aufmerksamkeit (1)
- Aufmerksamkeitsdefizit-Syndrom (1)
- Aurora-A (1)
- Aussterbedynamik (1)
- Autoantikörper (1)
- B cells (1)
- BDNF (1)
- BRCA1 (1)
- BTB domain (1)
- Bacillus subtilis (1)
- Bahnung (1)
- Bakterienzellwand (1)
- Basal Ganglia (1)
- Basalganglien (1)
- Bildanalyse (1)
- Biodistribution (1)
- Biogenese (1)
- Biolayerinterferometrie (1)
- Biologie (1)
- Bioluminescence resonance energy transfer (1)
- Biomarker (1)
- Biomaterial (1)
- Bioprinting (1)
- Bioreactor (1)
- Bioreaktor (1)
- Bitopic Ligands (1)
- Bitopische Liganden (1)
- Blickbewegung (1)
- Blickinteraktion (1)
- Blut-Rückenmarkschranke (1)
- Bordetella (1)
- Brain (1)
- Brain-derived neurotrophic factor (1)
- C. elegans (1)
- CCR4 (1)
- CD28 (1)
- CD28-SA (1)
- CD44 (1)
- CD84 (1)
- CDK4 Inhibitor (1)
- CDK4 inhibitor (1)
- CIDP (1)
- CMT1A (1)
- Caenorhabditis elegans (1)
- Camponotus rufipes (1)
- Candida albicans (1)
- Cardiac (1)
- Cardiomyocyte (1)
- Cartilage (1)
- Cartilage Tissue Engineering (1)
- Cataglyphis (1)
- Ccr4-Not (1)
- Celecoxib (1)
- Cell-Assisted Lipotransfer (1)
- Ceramide (1)
- Charcot-Marie-Tooth 1A (1)
- Chemotaxis (1)
- Chimeric antigen receptor (CAR) (1)
- Chimpanzee (1)
- Chronobiologie (1)
- Ciliary neurotrophic factor (1)
- Click-Chemie (1)
- Co-Kultur (1)
- Co-culture system (1)
- Cochlear-Implantat (1)
- Comoé National Park (1)
- Complement system (1)
- Conditioning (1)
- Cortico-striatal projection neurons (1)
- Craniosynostosis (1)
- Cushing-Syndrom (1)
- Cuticular transpiration (1)
- Cuticular waxes (1)
- Cyclo-AMP (1)
- Cystein (1)
- Cytoskeleton (1)
- DC (1)
- DNS-Reparatur (1)
- DOT1 (1)
- DTI (1)
- Danio rerio (1)
- Decapping (1)
- Deeplearning (1)
- Deletion (1)
- Dendritische Zelle (1)
- Depletion (1)
- Depression (1)
- Diabetes mellitus (1)
- Differential scanning calorimetry (1)
- Diffusionsgewichtete Magnetresonanztomografie (1)
- Drosophila (1)
- Drug resistance (1)
- Duplikation (1)
- E2 (1)
- ECAP (1)
- ECG-gated PET (1)
- EEG (1)
- Early-Life Stress (1)
- Echinococcus multilocularis (1)
- Effect anticipation (1)
- Effektantizipation (1)
- Einzelmolekülmikroskopie (1)
- Elektrostimulation (1)
- Entwicklung (1)
- Eosinophiler Granulozyt (1)
- Epigenetic (1)
- Epigenetik (1)
- Evolution (1)
- Expansion microscopy (1)
- Expansionsmikroskopie (1)
- Experimentelle autoimmune Enzephalomyelitis (1)
- Exposition (1)
- Expositionslernen (1)
- Expositionstherapie (1)
- Extinktion (1)
- Extracellular Vesicles (1)
- FLT3 inhibitor (1)
- FMS-like tyrosine kinase 3 (FLT3) (1)
- FRET (1)
- FT-IR-Spektroskopie (1)
- Ferroptosis (1)
- Fertilization in angiosperm (1)
- Fibromyalgia (1)
- Fibromyalgie (1)
- Fitness (1)
- Flavonoide (1)
- Flippase (1)
- Flow (1)
- Fluconazol (1)
- Fluconazole (1)
- Fluorescence correlation spectroscopy (1)
- Fluss (1)
- Folliculin (1)
- Foxo1 (1)
- Fragmentscreening (1)
- Functional analyses (1)
- Furagieraktivität (1)
- Furchtgeneralisierung (1)
- Förster Resonanz Energie Transfer (1)
- G glycoprotein (1)
- G-Protein gekoppelter Rezeptor (1)
- G-protein-coupled receptors (1)
- GMP (1)
- Gaze interaction (1)
- Gefäßwand (1)
- Gefäßwand-residente Stamm- und Vorläuferzellen (1)
- Gehirn (1)
- Gen BRCA 1 (1)
- Genetics (1)
- Genexpression (1)
- Genotoxicity (1)
- Genotoxizität (1)
- Genregulation (1)
- Gewebekultur (1)
- Glia (1)
- Glioblastom (1)
- Gliom (1)
- Glucose Starvation (1)
- Glutathion (1)
- Glycinrezeptor (1)
- Glycophyten (1)
- Glykomodifizierung (1)
- Glykosylierung (1)
- Gonococcal invasion (1)
- GvHD (1)
- H2A.Z (1)
- HECTD1 (1)
- HFpEF (1)
- Halophyten (1)
- Halophytes (1)
- Heart (1)
- Heart development (1)
- Heat stress (1)
- Helicobacter pylori (1)
- Herz (1)
- Herzinfarkt (1)
- Heubacillus (1)
- High-thropughput screening (1)
- Hippo pathway (1)
- Hippocampus (1)
- Hirnhaut (1)
- Histon-Methyltransferase (1)
- Histonacetyltransferase (1)
- Histone (1)
- Histone Acetylation (1)
- Histone modification (1)
- Histone variant (1)
- Hochauflösungsmikroskopie (1)
- Hochdurchsatz-Screening (1)
- Hornhaut (1)
- Huh6 (1)
- Human Transcriptome (1)
- Human-pathogenic (1)
- Hyaliner Knorpel (1)
- Hyaluronsäure (1)
- Hydrogel (1)
- Hypoxia (1)
- Hypoxie (1)
- Hämophilie A (1)
- Höhenangst (1)
- IKZF1 (1)
- IKZF3 (1)
- IRAK2 (1)
- Ideomotor gaze control (1)
- Ideomotorik (1)
- Ideomotorische Blickkontrolle (1)
- Ikaros (1)
- Immunological synapse (1)
- Immunozyt (1)
- Immunsystem (1)
- Immunzellrekrutierung (1)
- In-vitro-Kultur (1)
- Individualisierte Medizin (1)
- Infektion (1)
- Inflammation (1)
- Inhibitor (1)
- Insektenstaaten (1)
- Insulin (1)
- Interleukin (1)
- Interleukin 5 (1)
- Interleukin-4 Antagonist (1)
- Intracellular bacteria (1)
- Intrazelluläre Bakterien (1)
- Ischemia (1)
- Karotis-Intima-Media-Dicke (1)
- Kleine Proteine (1)
- Kleinkern (1)
- Knorpel (1)
- Kofaktorbindung (1)
- Kognition (1)
- Kognitive Beeinträchtigung (1)
- Komplement (1)
- Konditionierung (1)
- Konnektivitätsschätzung (1)
- Kopienzahlvariation (1)
- Kraniosynostose (1)
- Krebsforschung (1)
- Kutikula (1)
- Kutikularwachs (1)
- Künstliche Intelligenz (1)
- LPS Biosynthese (1)
- Labeling (1)
- Langerhans cells (1)
- Lasiocarpin (1)
- Latrophilin (1)
- Lebendzellmikroskopie (1)
- Leber-Metabolismus (1)
- Leishmania (1)
- Lenalidomid (1)
- Lernen (1)
- Letalität (1)
- Ligand <Biochemie> (1)
- Lipid Raft (1)
- Lipid Transfer Protein (1)
- Lipide (1)
- Lipolysis (1)
- Lung (1)
- Lunge (1)
- M1 Muscarinic Receptor (1)
- MEK5/ERK5 (1)
- MGMT (1)
- MIZ1 (1)
- MS2-affinity purification and RNA-seq (1)
- Macrophages (1)
- Magnetresonanztomographie (1)
- Makrophage (1)
- Marketing authorisation of pharmaceuticals (1)
- Mauerbiene (1)
- Mechanical deformation (1)
- Mechanismus (1)
- Medium spiny neurons (1)
- Megakaryocyte (1)
- Meninges (1)
- Merkel cell carcinoma (1)
- Merkel cell polyomavirus (1)
- Mesenchymal stem cell (1)
- Mesenchymal stromal cells (1)
- Mesenchymzelle (1)
- Metabolism (1)
- Metabolismus (1)
- Methylierung (1)
- MgrB (1)
- Microglia (1)
- Micronucleus (1)
- Microvesicle (1)
- Mikroglia (1)
- Mitochondria (1)
- Mitochondrien (1)
- Mitochondrium (1)
- Mittelohrimplantat (1)
- Model Organism (1)
- Modellorganismus (1)
- Modellsystem (1)
- Modifizierung (1)
- Monozyt (1)
- Morbus Alzheimer (1)
- Motor learning (1)
- Motorisches Lernen (1)
- Mouse Model (1)
- Mucormykose (1)
- Multiproteinkomplex (1)
- Mundschleimhautzellen (1)
- Muscarinrezeptor (1)
- Mutagenität (1)
- Myb-MuvB complex (1)
- Myeloid (1)
- Myokardinfarkt (1)
- N-Myc (1)
- NK cell (1)
- NK-DC cross-talk (1)
- NRF2 (1)
- NTRK fusions (1)
- Nasenschleimhaut (1)
- Natürliche Killerzelle (1)
- Neisseria gonorrhoeae (1)
- Neuartige Arzneimittel (1)
- Neuralgie (1)
- Neuroanatomie (1)
- Neuroethologie (1)
- Neuroinflammation (1)
- Neuronales visuelles System (1)
- Neuropathie (1)
- Neuropathischer Schmerz (1)
- Neuropeptide (1)
- Neuroprotektivum (1)
- Neuroscience (1)
- Neutrophil (1)
- Neutrophil granulocyte (1)
- Neutrophiler Granulozyt (1)
- Nozizeption (1)
- Nucleotide excision repair (1)
- Nukleotid-Exzisions-Reparatur (1)
- O(6)-Methylguanine-DNA Methyltransferase (1)
- Obesity (1)
- Opiatrezeptor (1)
- Opioide (1)
- Oxidativer Stress (1)
- Oxygen partial pressure (1)
- P4-ATPase (1)
- PAF1c (1)
- PDE (1)
- PRR (1)
- PVM (1)
- Palbociclib (1)
- Parc National de la Comoé (1)
- Parkinson Krankheit (1)
- Parkinson's disease (1)
- Pathogenität (1)
- Pathophysiologie (1)
- Pathophysiologische Mechanismen (1)
- Pattern-Recognition-Receptors (1)
- Persistence (1)
- Pertussis (1)
- Pflanzenaussterben (1)
- Phasenvariation (1)
- Phenotypic switch (1)
- Phosphodiesterase (1)
- Pilzkörper (1)
- PinT (1)
- Plant cuticle (1)
- Plasmamembran (1)
- Plastizität (1)
- Pneumoviruses (1)
- Pollen (1)
- Positronen-Emissions-Tomografie (1)
- Preclinical studies (1)
- Primäre Ziliendyskinesie (1)
- Primärelement (1)
- Primärzellen (1)
- Progenitor (1)
- Protein purification (1)
- Protein-Protein-Interaktion (1)
- Protein-Protein-Wechselwirkung (1)
- Proteinkinase D (1)
- Proteinmodifizierung (1)
- Präklinische Studien (1)
- Präzisionsmedizin (1)
- Psychotherapie (1)
- Punktmutation (1)
- Pyrrolizidinalkaloide (1)
- QPCR (1)
- Qualitätsindikator (1)
- RNS-Interferenz (1)
- RSV (1)
- Receptor dynamics (1)
- Regenerative Medicine (1)
- Regulation (1)
- Regulatorischer T-Lymphozyt (1)
- Resilienz (1)
- Resistance (1)
- Respiratorisches System (1)
- Rezeptorblocker (1)
- Rezidiv (1)
- Rhizopus arrhizus (1)
- Ribonuclease H2 (1)
- Riboregulation (1)
- Risikofaktoren (1)
- Rossameise (1)
- Röntgenkristallographie (1)
- SLC2A3 (1)
- SMN (1)
- Salmonella (1)
- Salmonella Typhimurium (1)
- Scaffold bone implant (1)
- Schimpanse (1)
- Schizosaccharomyces pombe (1)
- Schlaganfall (1)
- Schließzellfunktion (1)
- Secretion (1)
- Sekundäre Inflammation (1)
- Selective extraction (1)
- Senecionin (1)
- Seneciphyllin (1)
- Sequenzwiederholung (1)
- Serotonindefizienz (1)
- Signaltransduktion (1)
- Sleeping Beauty Transposon System (1)
- Small RNA (1)
- Small angle X-ray scattering (1)
- Social action effects (1)
- Sociomotor gaze control (1)
- Soziale Handlungseffekte (1)
- Soziomotorische Blickkontrolle (1)
- SteC (1)
- Sterblichkeit (1)
- Stiff-Person Syndrom (1)
- Stiff-person syndrome (1)
- Stress (1)
- Striatum (1)
- Strukturbiologie (1)
- Superresolution microscopy (1)
- Survival Motor Neuron (1)
- Synaptic plasticity (1)
- Synchronitätsmessung (1)
- T cell engaging Antibody (1)
- TFIIH (1)
- TH2 Immunantwort (1)
- TLR signaling (1)
- Telomerase (1)
- Thebain (1)
- Therapie (1)
- Therapieresistenz (1)
- Thrombopoiesis (1)
- Tight junction (1)
- Tissue engineering (1)
- Toll-like-Rezeptoren (1)
- TraDIS (1)
- Transkription (1)
- Transkriptionsfaktor (1)
- Transkriptomanalyse (1)
- Transkriptomik anlyze (1)
- Transpiration <Pflanzen> (1)
- Transposon (1)
- Treg (1)
- Trend (1)
- Trophic Factors (1)
- Trypanosoma Brucei (1)
- Trypanosoma brucei (1)
- UBE2S (1)
- Ubiquitin-PA (1)
- Ubiquitin-Protein-Ligase (1)
- Ubiquitin-conjugating enzyme (1)
- Ubiquitinierung (1)
- VW-SCs (1)
- Validierung (1)
- Verhalten (1)
- Verhaltenskontrolle (1)
- Very-long-chain aliphatic (1)
- Vesikelbildung (1)
- Vessel wall (1)
- Virtuelle Realität (1)
- Visuelle Aufmerksamkeit (1)
- Vorläufer (1)
- Water stress (1)
- Wirkstoffdesign (1)
- X-ray crystallography (1)
- X-ray diffraction (1)
- Yeast (1)
- Zellzyklus (1)
- Zink-Finger-Proteine (1)
- aGPCR (1)
- acute graft-versus host disease (1)
- adhesion-GPCR (1)
- adrenal gland (1)
- adrenergic receptor (1)
- adrenocortical carcinoma (1)
- airways (1)
- allogeneic stem cell transplantation (1)
- alloreactive T cells (1)
- antimicrobial (1)
- anxiety disorders (1)
- articular cartilage progenitor cells (1)
- atopic diseases (1)
- attributable fraction (1)
- attributable risk (1)
- autoantibody (1)
- autophagocytose (1)
- autophagy (1)
- bacterial lipid rafts (1)
- behavior (1)
- beta-Arrestin2 (1)
- bicuculline (1)
- binding mode (1)
- biochemistry (1)
- biodistribution (1)
- bioimage analysis (1)
- biokinetics (1)
- biolayerinterferometry (1)
- bioreactor (1)
- blood nerve barrier (1)
- bone marrow (1)
- bumblebee*s (1)
- cancer (1)
- candida (1)
- candida albicans (1)
- cartilage (1)
- chlamydia (1)
- chondrogene Differenzierung (1)
- circadian rhythms (1)
- claudin-12 (1)
- co-culture (1)
- cochlea implant (1)
- cofactorbinding (1)
- compartments (1)
- corneal confocal microscopy (1)
- correlation (1)
- cushing's syndrome (1)
- cytokine release syndrome (1)
- cytoskeleton (1)
- dCIRL (1)
- dSTORM (1)
- developmental differentiation (1)
- diabetic cardiomyopathy (1)
- diagnostics (1)
- diastolic dysfunction (1)
- diet (1)
- disease model (1)
- distance (1)
- distribution (1)
- double-strand break repair (1)
- drug repurposing (1)
- dual RNA-seq (1)
- ecology (1)
- effector protein (1)
- electron microscopy (1)
- eosinophil (1)
- evozierte Potentiale (1)
- exposition training (1)
- expression (1)
- extinction dynamics (1)
- fabry disease (1)
- fear conditioning (1)
- fibromyalgia sydrome (1)
- foraging activity (1)
- foxtapeworm (1)
- fragment screening (1)
- functional membrane microdomains (1)
- functional studies (1)
- fungus (1)
- genotoxicity (1)
- germinative cell (1)
- gezielte Therapie (1)
- glycine receptor autoantibodies (1)
- glycophytes (1)
- guard cells (1)
- habitat (1)
- hematopoiesis (1)
- hippocampus (1)
- homoFRET (1)
- honeybee (1)
- honeybee*s (1)
- huh6 (1)
- iPSC (1)
- in vitro Kulturmodelle (1)
- in vitro Testsystem (1)
- interleukin-5 signaling (1)
- internal dosimetry (1)
- interphase gap (1)
- interpulse interval (1)
- intraoperative Ankopplungseffizienz (1)
- kinase (1)
- labeling techniques (1)
- lasiocarpine (1)
- learning (1)
- lipid rafts (1)
- lymph node stromal cells (1)
- lymph node transplantation (1)
- mechanistische Modellierung (1)
- melanoma dedifferentiation (1)
- membrane dynamics (1)
- mesenteric lymph node (1)
- metabolic theory of ecology (1)
- microelectrode array (1)
- mouse models (1)
- mucormycosis (1)
- myelin barrier (1)
- neuroethology (1)
- neuromodulation (1)
- neuronal visual system (1)
- neuropeptides (1)
- neutrophil (1)
- nociception (1)
- nutrients (1)
- nutrition (1)
- p97 (1)
- pain (1)
- pathophysiological mechanisms (1)
- peptide (1)
- peptide engineering (1)
- peptide-based interleukin-5 inhibitor (1)
- perception (1)
- phosphorylation (1)
- platelets (1)
- polarized epithelium (1)
- pollen (1)
- polyethism (1)
- polyradiculoneuropathy (1)
- population attributable fraction (1)
- precision medicine (1)
- preclinical PET (1)
- primary ciliary dyskinesia (1)
- primate (1)
- proboscis extension response (1)
- protease (1)
- protein kinase a (1)
- protein regulation and expression (1)
- protein-protein-interaction (1)
- psychosocial resilience (1)
- rapid evolution (1)
- reception (1)
- receptor (1)
- replication (1)
- resilience (1)
- salinen Wachstumsbedingungen (1)
- salt stress (1)
- schnelle Evolution (1)
- self-activation (1)
- senecionine (1)
- seneciphylline (1)
- shRNA (1)
- signalling (1)
- similarity (1)
- skin (1)
- skin biopsy (1)
- small RNA (1)
- small fiber pathology (1)
- small proteins (1)
- somatic resilience (1)
- somatostatin receptor antagonists (1)
- sphingolipids (1)
- ssVEP (1)
- stiff person syndrome (1)
- structural mechanism (1)
- structure analysis (1)
- super-resolution microscopy (1)
- synaptic plasticity (1)
- synaptische Plastizität (1)
- targeted therapy (1)
- tdcs (1)
- temporal information transfer (1)
- test system (1)
- therapy (1)
- time-resolved anisotropy (1)
- tool (1)
- tool-use (1)
- tracheal cytotoxin (1)
- trachomatis (1)
- transcription/replication conflicts (1)
- transcriptome data analysis (1)
- transcriptomic analysis (1)
- transient dynamics (1)
- tumour (1)
- tyrosine kinase (1)
- virulence (1)
- yeast (1)
- zeitlich Informationsübertragung (1)
- zonal Hydrogels (1)
- µ-Opioid Rezeptor (1)
- Ängstliche Depression (1)
Institute
- Graduate School of Life Sciences (124) (remove)
Sonstige beteiligte Institutionen
- Biomedical Center Munich, Department of Physiological Chemistry, Ludwig-Maximilians-Universität München (1)
- Department of Veterinary Sciences, Experimental Parasitology, Ludwig-Maximilians-Universität München (1)
- Max-Delbrück-Center für molekulare Medizin, Berlin (1)
- Research Center for Infectious Diseases, University of Würzburg (1)
- Spanish National Center for Biotechnology (CNB-CSIC) (1)
- Technische Universität Darmstadt (1)
- University of Applied Sciences Aschaffenburg (1)
- University of Leipzig, Faculty of Life Sciences, Institute for Biology (1)
- Zentrum für Infektionsforschung (ZINF) Würzburg (1)
The putative attachment protein G of pneumonia virus of mice (PVM), a member of the Pneumoviruses, is an important virulence factor with so far ambiguous function in a virus-cell as well as in virus-host context. The sequence of the corresponding G gene is characterized by significant heterogeneity between and even within strains, affecting the gene and possibly the protein structure. This accounts in particular for the PVM strain J3666 for which two differing G gene organizations have been described: a polymorphism in nucleotide 65 of the G gene results in the presence of an upstream open reading frame (uORF) that precedes the main ORF in frame (GJ366665A) or extension of the major G ORF for 18 codons (GJ366665U). Therefore, this study was designed to analyse the impact of the sequence variations in the respective G genes of PVM strains J3666 and the reference strain 15 on protein expression, replication and virulence.
First, the controversy regarding the consensus sequence of PVM J3666 was resolved. The analysis of 45 distinct cloned fragments showed that the strain separated into two distinct virus populations defined by the sequence and structure of the G gene. This division was further supported by nucleotide polymorphisms in the neighbouring M and SH genes. Sequential passage of this mixed strain in the cell line standardly used for propagation of virus stocks resulted in selection for the GJ366665A-containing population in one of two experiments pointing towards a moderate replicative advantage. The replacement of the G gene of the recombinant PVM 15 with GJ366665A or GJ366665U, respectively, using a reverse genetic approach indicated that the presence of uORF within the GJ366665A significantly reduced the expression of the main G ORF on translational level while the potential extension of the ORF in GJ366665U increased G protein expression. In comparison, the effect of the G gene-structure on virus replication was inconsistent and dependent on cell line and type. While the presence of uORF correlated with a replication advantage in the standardly used BHK-21 cells and primary murine embryonic fibroblasts, replication in the murine macrophage cell line RAW 264.7 did not. In comparison, the GJ366665U variant was not associated with any effect on replication in cultured cells at all. Nonetheless, in-vivo analysis of the recombinant viruses associated the GJ366665U gene variant, and hence an increased G expression, with higher virulence whereas the GJ366665A gene, and therefore an impaired G expression, conferred an attenuated phenotype to the virus.
To extend the study to other G gene organizations, a recombinant PVM expressing a G protein without the cytoplasmic domain and for comparison a G-deletion mutant, both known to be attenuated in vivo, were studied. Not noticed before, this structure of the G gene was associated with a 75% reduction in G protein expression and a significant attenuation of replication in macrophage-like cells. This attenuation was even more prominent for the virus lacking G. Taking into consideration the higher reduction in G protein levels compared to the GJ366665A variant indicates that a threshold amount of G is required for efficient replication in these cells.
In conclusion, the results gathered indicated that the expression levels of the G protein were modulated by the sequence of the 5’ untranslated region of the gene. At the same time the G protein levels modulated the virulence of PVM.
The superfamily of G protein-coupled receptors (GPCRs) comprises more than 800 members, which are divided into five families based on phylogenetic analyses (GRAFS classification): Glutamate, Rhodopsin, Adhesion, Frizzled/Taste2 and Secretin. The adhesion G protein-coupled receptor (aGPCR) family forms with 33 homologs in Mammalia the second largest and least investigated family of GPCRs. The general architecture of an aGPCR comprises the GPCR characteristics of an extracellular region (ECR), a seven transmembrane (7TM) domain and an intracellular region (ICR). A special feature of aGPCRs is the extraordinary size of the ECR through which they interact with cellular and matricellular ligands via adhesion motif folds. In addition, the ECR contains a so-called GPCR autoproteolysis-inducing (GAIN) domain, which catalyzes autoproteolytic cleavage of the protein during maturation. This cleavage leads to the formation of an N-terminal (NTF) and a C-terminal fragment (CTF), which build a unit by means of hydrophobic interactions and therefore appear as a heterodimeric receptor at the cell surface. In the past, it has been shown that the first few amino acids of the CTF act as a tethered agonist (TA) that mediates the activation of the receptor through the interaction with the 7TM domain. However, the molecular mechanism promoting the TA-7TM domain interaction remains elusive. This work reveals a novel molecular mechanism that does not require the dissociation of the NTF-CTF complex to promote release of the TA and thus activation of the aGPCR. The introduction of bioorthogonal labels into receptorsignaling- relevant regions of the TA of various aGPCRs demonstrated that the TA is freely accessible within the intact GAIN domain. This suggests a structural flexibility of the GAIN domain, which allows a receptor activation independent of the NTF-CTF dissociation, as found in cleavage-deficient aGPCR variants. Furthermore, the present study shows that the cellular localization and the conformation of the 7TM domain depends on the activity state of the aGPCR, which in turn indicates that the TA mediates conformational changes through the interaction with the 7TM domain, which ultimately regulates the receptor activity. In addition, biochemical analyses showed that the GAIN domain-mediated autoproteolysis of the human aGPCR CD97 (ADGRE5/E5) promotes further cleavage events within the receptor. This suggests that aGPCRs undergo cleavage cascades, which are initialized by the autoproteolytic reaction of the GAIN domain. Thus, it can be assumed that aGPCRs are subject to additional proteolytic events. Finally, the constitutive internalization of the NTF and the CTF of E5 was demonstrated by various labeling methods. It was possible to label both fragments independently and to follow their subcellular location in vitro. In summary, these obtained results contribute to a better understanding about the molecular mechanisms of activity and signaling of aGPCRs.
Effects of dopamine on BDNF / TrkB mediated signaling and plasticity on cortico-striatal synapses
(2021)
Progressive loss of voluntary movement control is the central symptom of Parkinson's disease (PD). Even today, we are not yet able to cure PD. This is mainly due to a lack of understanding the mechanisms of movement control, network activity and plasticity in motor circuits, in particular between the cerebral cortex and the striatum. Brain-derived neurotrophic factor (BDNF) has emerged as one of the most important factors for the development and survival of neurons, as well as for synaptic plasticity. It is thus an important target for the development of new therapeutic strategies against neurodegenerative diseases. Together with its receptor, the Tropomyosin receptor kinase B (TrkB), it is critically involved in development and function of the striatum. Nevertheless, little is known about the localization of BDNF within presynaptic terminals in the striatum, as well as the types of neurons that produce BDNF in the cerebral cortex. Furthermore, the influence of midbrain derived dopamine on the control of BDNF / TrkB interaction in striatal medium spiny neurons (MSNs) remains elusive so far. Dopamine, however, appears to play an important role, as its absence leads to drastic changes in striatal synaptic plasticity. This suggests that dopamine could regulate synaptic activity in the striatum via modulation of BDNF / TrkB function. To answer these questions, we have developed a sensitive and reliable protocol for the immunohistochemical detection of endogenous BDNF. We find that the majority of striatal BDNF is provided by glutamatergic, cortex derived afferents and not dopaminergic inputs from the midbrain. In fact, we found BDNF in cell bodies of neurons in layers II-III and V of the primary and secondary motor cortex as well as layer V of the somatosensory cortex. These are the brain areas that send dense projections to the dorsolateral striatum for control of voluntary movement. Furthermore, we could show that these projection neurons significantly downregulate the expression of BDNF during the juvenile development of mice between 3 and 12 weeks.
In parallel, we found a modulatory effect of dopamine on the translocation of TrkB to the cell surface in postsynaptic striatal Medium Spiny Neurons (MSNs). In MSNs of the direct pathway (dMSNs), which express dopamine receptor 1 (DRD1), we observed the formation of TrkB aggregates in the 6-hydroxydopamine (6-OHDA) model of PD. This suggests that DRD1 activity controls TrkB surface expression in these neurons. In contrast, we found that DRD2 activation has opposite effects in MSNs of the indirect pathway (iMSNs). Activation of DRD2 promotes a rapid decrease in TrkB surface expression which was reversible and depended on cAMP. In parallel, stimulation of DRD2 led to induction of phospho-TrkB (pTrkB). This effect was significantly slower than the effect on TrkB surface expression and indicates that TrkB is transactivated by DRD2. Together, our data provide evidence that dopamine triggers dual modes of plasticity on striatal MSNs by acting on TrkB surface expression in DRD1 and DRD2 expressing MSNs. This surface expression of the receptor is crucial for the binding of BDNF, which is released from corticostriatal afferents. This leads to the induction of TrkB-mediated downstream signal transduction cascades and long-term potentiation (LTP). Therefore, the dopamine-mediated translocation of TrkB could be a mediator that modulates the balance between dopaminergic and glutamatergic signaling to allow synaptic plasticity in a spatiotemporal manner. This information and the fact that TrkB is segregated to persistent aggregates in PD could help to improve our understanding of voluntary movement control and to develop new therapeutic strategies beyond those focusing on dopaminergic supply.
Cyclic adenosine monophosphate (cAMP), the ubiquitous second messenger produced upon stimulation of GPCRs which couple to the stimulatory GS protein, orchestrates an array of physiological processes including cardiac function, neuronal plasticity, immune responses, cellular proliferation and apoptosis. By interacting with various effector proteins, among others protein kinase A (PKA) and exchange proteins directly activated by cAMP (Epac), it triggers signaling cascades for the cellular response. Although the functional outcomes of GSPCR-activation are very diverse depending on the extracellular stimulus, they are all mediated exclusively by this single second messenger. Thus, the question arises how specificity in such responses may be attained. A hypothesis to explain signaling specificity is that cellular signaling architecture, and thus precise operation of cAMP in space and time would appear to be essential to achieve signaling specificity. Compartments with elevated cAMP levels would allow specific signal relay from receptors to effectors within a micro- or nanometer range, setting the molecular basis for signaling specificity. Although the paradigm of signaling compartmentation gains continuous recognition and is thoroughly being investigated, the molecular composition of such compartments and how they are maintained remains to be elucidated. In addition, such compartments would require very restricted diffusion of cAMP, but all direct measurements have indicated that it can diffuse in cells almost freely.
In this work, we present the identification and characterize of a cAMP signaling compartment at a GSPCR. We created a Förster resonance energy transfer (FRET)-based receptor-sensor conjugate, allowing us to study cAMP dynamics in direct vicinity of the human glucagone-like peptide 1 receptor (hGLP1R). Additional targeting of analogous sensors to the plasma membrane and the cytosol enables assessment of cAMP dynamics in different subcellular regions. We compare both basal and stimulated cAMP levels and study cAMP crosstalk of different receptors. With the design of novel receptor nanorulers up to 60nm in length, which allow mapping cAMP levels in nanometer distance from the hGLP1R, we identify a cAMP nanodomain surrounding it. Further, we show that phosphodiesterases (PDEs), the only enzymes known to degrade cAMP, are decisive in constraining cAMP diffusion into the cytosol thereby maintaining a cAMP gradient. Following the discovery of this nanodomain, we sought to investigate whether downstream effectors such as PKA are present and active within the domain, additionally studying the role of A-kinase anchoring proteins (AKAPs) in targeting PKA to the receptor compartment. We demonstrate that GLP1-produced cAMP signals translate into local nanodomain-restricted PKA phosphorylation and determine that AKAP-tethering is essential for nanodomain PKA.
Taken together, our results provide evidence for the existence of a dynamic, receptor associated cAMP nanodomain and give prospect for which key proteins are likely to be involved in its formation. These conditions would allow cAMP to exert its function in a spatially and temporally restricted manner, setting the basis for a cell to achieve signaling specificity. Understanding the molecular mechanism of cAMP signaling would allow modulation and thus regulation of GPCR signaling, taking advantage of it for pharmacological treatment.
Platelets are small anucleated cell fragments that originate from megakaryocytes (MKs), which are large cells located in the bone marrow (BM). MKs extend long cytoplasmic protrusions, a process which is called proplatelet formation, into the lumen of the sinusoidal vessels where platelets are sized by the bloodstream. During the process of platelet biogenesis, segments of the MK penetrate the endothelium and, through cytoskeletal remodeling inside the MK, proplatelet fragments are released. Rho GTPases, such as RhoA and RhoB, are critically involved in cytoskeletal rearrangements of both the actin and the tubulin cytoskeleton.
The first part of this thesis concentrated on the protein RhoB and its involvement in cytoskeletal organization in MKs and platelets. Single knockout (KO) mice lacking RhoB had a minor microthrombocytopenia, which means a smaller platelet size and reduced platelet number, accompanied by defects in the microtubule cytoskeleton in both MKs and platelets. In particular, tubulin organization and stability, which is regulated by posttranslational modifications of α-tubulin, were disturbed in RhoB-/- platelets. In contrast, RhoB-/- MKs produced abnormally shaped proplatelets but had unaltered posttranslational modifications of α-tubulin.
The second part focused on the influence of RhoA and RhoB on MK localization and platelet biogenesis in murine BM. Many intact RhoA-/- MKs are able to transmigrate through the endothelial layer and stay attached to the vessel wall, whereas only 1% of wildtype (wt) MKs are detectable in the intrasinusoidal space. Concomitant deficiency of RhoA and RhoB reverts this transmigration and results in macrothrombocytopenia, MK clusters around the vessel in the BM and defective MK development. The underlying mechanism that governs MKs to distinct localizations in the BM is poorly understood, thus this thesis suggests that this process may be dependent on RhoB protein levels, as RhoA deficiency is coincided with increased RhoB levels in MKs and platelets.
The third part of this thesis targeted the protein PDK1, a downstream effector of Rho GTPases, in regard to MK maturation and polarization throughout thrombopoiesis. MK- and platelet-specific KO in mice led to a significant macrothrombocytopenia, impaired actin cytoskeletal reorganization during MK spreading and proplatelet formation, with defective MK maturation. This was associated with decreased PAK activity and, subsequently, phosphorylation of its substrates LIMK and Cofilin. Together, the observations of this thesis highlight the importance of Rho GTPases and their downstream effectors on the regulation of the MK and platelet cytoskeleton.
Angsterkrankungen gehören zu den am weitesten verbreiteten psychischen Erkrankungen und stellen eine beträchtliche soziale und wirtschaftliche Herausforderung für unsere Gesellschaft dar. Aversive frühe Erfahrungen sind ein bekannter Risikofaktor für die Entwicklung verschiedener psychischer Erkrankungen, insbesondere Angststörungen. Während der frühen Entwicklung findet die Programmierung der Hypothalamus-Hypophysen-Nebennierenrinden- (HHN)-Achse, die die Ausschüttung des Stresshormons Cortisol in Menschen bzw. Corticosteron in Mäusen steuert, statt. Wenn Individuen in dieser kritischen Phase Stress ausgesetzt sind, wird die regelrechte Ausbildung der HHN-Achse gestört, was zu dysregulierten Verhaltensantworten auf Stressreize im späteren Leben führen kann. Das Serotonin (5-HT)-System als eines der ausgedehntesten Neurotransmittersysteme ist an der Vermittlung der Effekte von früher Stressexposition auf angstähnliche Verhaltensweisen beteiligt.
Das Ziel dieser Studie ist es, die Interaktion zwischen genetischer Prädisposition und negativen Einflüssen in frühen Entwicklungsstadien auf die Ausbildung von Angstverhalten im Erwachsenenalter näher zu beleuchten.
In dieser Studie wurden Tryptophanhydroxylase 2 (Tph2)-defiziente weibliche Mäuse als Modell für ein lebenslanges konstitutives 5-HT Synthesedefizit im zentralen Nervensystem verwendet. Nachkommen dieser Mauslinie wurden im frühen Lebensalter Maternaler Separation (MS), d.h. einem mütterlichen Trennungsparadigma, unterzogen und im Erwachsenenalter im „Open field“ (OF) oder in der „Dark-light box“ (DLB) getestet. Im Anschluss an die Verhaltensexperimente wurde die neuronale Aktivierung immunhistochemisch durch Darstellung des frühzeitig auftretenden Genprodukts c-Fos bestimmt.
In der DLB zeigten homozygot Tph2-defiziente Mäuse eine verringerte motorische Aktivität im hellen Kompartiment, und dieser Effekt konnte durch MS normalisiert werden. Zusätzlich verstärkte MS bei diesem Genotyp das Auftreten von fluchtartigen Sprüngen. Im OF hat MS fluchtartige Verhaltensweisen in homo- und heterozygoten Tph2-defizienten Mäusen befördert.
Beide Verhaltenstests führten zu spezifischen neuronalen Aktivierungsmustern, die mithilfe von c-Fos- Immunhistochemie ausgewertet wurden. Die Durchführung des DLB-Tests führte in Abhängigkeit vom Vorhandensein von Tph2 zur Aktivierung des paraventrikulären Kerns des Hypothalamus (PVN) und der basolateralen Amygdala (BL), wohingegen die Exposition gegenüber dem OF-Test zu einer Aktivierung der lateralen Amygdala (La) in Tieren, die einem mütterlichen Trennungsparadigma unterzogen wurden, sowie einer Aktivierung des ventrolateralen (VLPAG) und dorsolateralen (DLPAG) periaquäduktalen Höhlengraus in Abhängigkeit von Tph2 und MS führte.
Zusammenfassend weisen die Ergebnisse dieser Studie darauf hin, dass MS aktive Verhaltensantworten auf aversive Reize in Abhängigkeit vom Vorhandensein von 5-HT im Gehirn fördert. Diese Effekte könnten durch die spezifische Aktivierung von mit Angstverhalten in Zusammenhang stehenden Gehirnregionen während der Verhaltensexperimente vermittelt werden.
The use of human adipose-derived mesenchymal stem cells (ASCs) for cell-based therapeutic approaches, in terms of repair and regeneration of various tissues and organs, offers an alternative therapeutic tool in the field of regenerative medicine. The ability of ASCs to differentiate along mesenchymal lineages is not the only property that makes these cells particularly attractive for therapeutic purposes. Their promising functions in promoting angiogenesis, reducing inflammation as well as in functional tissue restoration are largely related to the trophic effects of a broad panel of secreted cytokines and growth factors. However, in cell-based approaches, the cell-loaded construct often is exposed to an ischemic microenvironment characterized by severe oxidative and nutritional stress after transplantation due to the initial lack of vascular connection, resulting in reduced cell viability and altered cell behaviour. Therefore, the effective use of ASCs in regenerative medicine first requires a comprehensive characterization of the cells in terms of their viability, differentiation capacity and especially their secretory capabilities under ischemia-mimicking conditions in order to better understand their beneficial role. Accordingly, in the first part of this work, ASCs were investigated under different ischemic conditions, in which cells were exposed to both glucose and oxygen deprivation, with respect to viability and secretory function. Using mRNA gene expression analysis, significantly higher expression of selected angiogenic, anti-apoptotic and immunomodulatory factors (IL-6, VEGF, STC-1) could be demonstrated under harsh ischemic conditions. These results were reflected at the protein expression level by a significantly increased secretion of these factors. For stanniocalcin-1 (STC-1), a factor not yet described in ASCs, a particularly high expression with significant secreted amounts of the protein could be demonstrated under harsh ischemic conditions. Thus, the first part of this work, in addition to the characterization of the viability, provided first insights into the secretory response of ASCs under ischemic conditions.
The response of ASCs to glucose deficiency in combination with severe hypoxia has been little explored to date. Thus, the focus of the second part of this work was on a more detailed investigation of the secretory response of ASCs under glucose and oxygen deprivation. For a more comprehensive analysis of the secretion profile, a cytokine antibody array was performed, which allowed the detection of a broad panel of secreted angiogenic factors
(IL-8, ANG), matrix-regulating proteins (TIMP-1, TIMP-2), chemokines (MCP-1/CCL2,
IP-10/CXCL 10) and other factors under ischemic conditions. To verify these results, selected factors were examined using ELISA. The analysis revealed that the secretion of individual factors (e.g., STC-1, VEGF) was significantly upregulated by the combination of glucose and oxygen deprivation compared to oxygen deprivation alone.
In order to investigate the impact of the secretome of ischemic ASCs on cell types involved in tissue regeneration, the effect of conditioned medium of ischemia-challenged ASCs on both endothelial cells and fibroblasts was investigated in subsequent experiments. Significantly increased viability and tube formation of endothelial cells as well as activated migration of fibroblasts by the secreted factors of ischemic ASCs could be demonstrated. A direct correlation of these effects to STC-1, which was significantly upregulated under ischemic conditions and has been described as a regulator of key cellular functions, could not be verified.
The particular secretory capacity of ASCs provides a valuable tool for cell-based therapies, such as cell-assisted lipotransfer (CAL), where by enriching fat grafts with isolated ASCs, a significantly improved survival rate of the transplanted construct is achieved with less resorption of the fat tissue as well as a reduction in adverse implications, such as fibrosis and cyst formation. In order to better understand the function of ASCs in CAL, an autologous transwell-based lipograft-ASC co-culture was established in the last part of this work, in which first investigations showed a markedly increased secretion of VEGF compared to lipografts without added ASCs. As the stability rate of the fat tissue and thus the success of CAL is presumably also dependent on the preparation of the tissue before transplantation, the conventional preparation method of fat tissue for vocal fold augmentation in laryngoplasty was additionally evaluated in vitro in a pilot experiment. By analyzing the viability and tissue structure of the clinically prepared injection material, a large number of dead cells and a clearly damaged tissue structure with necrotic areas could be demonstrated. In comparison, the preparation method of the fat tissue established in this work as small tissue fragments was able to provide a clearly intact, vital, and vascularized tissue structure. This type of adipose tissue preparation represents a promising alternative for clinical vocal fold augmentation.
In conclusion, the results of this work contribute to a comprehensive characterization of ASCs under ischemic conditions, such as those prevalent at the transplantation site or in tissue regeneration. The results obtained, especially on the secretory capacity of ASCs, provide new insights into how ASCs mediate regenerative effects in an ischemic milieu and why their use for therapeutic purposes is highly attractive and promising.
G-protein- coupled receptors (GPCRs) are the largest family of membrane confined receptors and they transduce ligand binding to downstream effects. Almost 40% of the drugs in the world target GPCRs due to their function, albeit knowing less about their activation. Understanding their dynamic behaviour in basal and activated state could prove key to drug development in the future. GPCRs are known to exhibit complex molecular mobility patterns. A plethora of studies have been and are being conducted to understand the mobility of GPCRs. Due to limitations of imaging and spectroscopic techniques commonly used, the relevant timescales are hard to access. The most commonly used techniques are electron paramagnetic resonance or double electronelectron resonance, nuclear magnetic resonance, time-resolved fluorescence, single particle tracking and fluorescence recovery after photobleaching. Among these techniques only fluorescence has the potential to probe live cells. In this thesis, I use different time-resolved fluorescence spectroscopic techniques to quantify diffusion dynamics / molecular mobility of β2-adrenergic receptor (β2-AR) in live cells. The thesis shows that β2-AR exhibits mobility over an exceptionally broad temporal range (nanosecond to second) that can be linked to its respective physiological scenario. I explain how β2-AR possesses surprisingly fast lateral mobility (~10 μm²/s) associated with vesicular transport in contrast to the prior reports of it originating from fluorophore photophysics and free fluorophores in the cytosol. In addition, β2-AR has rotational mobility (~100 μs) that makes it conform to the Saffman-Delbrück model of membrane diffusion unlike earlier studies. These contrasts are due to the limitations of the methodologies used. The limitations are overcome in this thesis by using different time-resolved fluorescence techniques of fluorescence correlation spectroscopy (FCS), time-resolved anisotropy (TRA) and polarisation resolved fullFCS (fullFCS). FCS is limited to microsecond to the second range and TRA is limited to the nanosecond range. fullFCS complements the two techniques by covering the blind spot of FCS and TRA in the microsecond range. Finally, I show how ligand stimulation causes a decrease in lateral mobility which could be a hint at cluster formation due to internalisation and how β2-AR possesses a basal oligomerisation that does not change on activation. Thus, through this thesis, I show how different complementary fluorescence techniques are necessary to overcome limitations of each technique and to thereby elucidate functional dynamics of GPCR activation and how it orchestrates downstream signalling.
Expression of the MYC oncoprotein, which binds the DNA at promoters of most transcribed genes, is controlled by growth factors in non-tumor cells, thus stimulating cell growth and proliferation.
Here in this thesis, it is shown that MYC interacts with SPT5, a subunit of the RNA polymerase II (Pol II) elongation factor DSIF. MYC recruits SPT5 to promoters of genes and is required for its association with Pol II. The transfer of SPT5 is mediated by CDK7 activity on TFIIE, which evicts it from Pol II and allows SPT5 to bind Pol II.
MYC is required for fast and processive transcription elongation, consistent with known functions of SPT5 in yeast. In addition, MYC increases the directionality of promoters by stimulating sense transcription and by suppressing the synthesis of antisense transcripts.
The results presented in this thesis suggest that MYC globally controls the productive assembly of Pol II with general elongation factors to form processive elongation complexes in response to growth-factor stimulation of non-tumour cells. However, MYC is found to be overexpressed in many tumours, and is required for their development and progression.
In this thesis it was found that, unexpectedly, such overexpression of MYC does not further enhance transcription but rather brings about squelching of SPT5. This reduces the processivity of Pol II on selected set of genes that are known to be repressed by MYC, leading to a decrease in growth-suppressive gene transcription and uncontrolled tumour growth
Platelets, small anucleate cell fragments in the blood stream, derive from large precursor cells, so-called megakaryocytes (MK) residing in the bone marrow (BM). In addition to their role in wound healing, platelets have been shown to play a significant role during inflammatory bleeding. Above all, the immunoreceptor tyrosine-based activation motif (ITAM) receptors GPVI as well as CLEC-2 have been identified as main regulators of vascular integrity.
In addition to ITAM-bearing receptors, our group identified GPV as another potent regulator of hemostasis and thrombosis. Surprisingly, concomitant lack of GPV and CLEC-2 deteriorated blood-lymphatic misconnections observed in Clec2-/- mice resulting in severe edema formation and intestinal inflammation. Analysis of lymphatic and vascular development in embryonic mesenteries revealed severely defective blood-lymph-vessel separation, which translated into thrombocytopenia and increased vascular permeability due to reduced tight junction density in mesenteric blood vessels and consequent leakage of blood into the peritoneal cavity.
Recently, platelet granule release has been proposed to ameliorate the progression of retinopathy of prematurity (ROP), a fatal disease in newborns leading to retinal degradation. The mechanisms governing platelet activation in this process remained elusive nonetheless, which prompted us to investigate a possible role of ITAM signaling. In the second part of this thesis, granule release during ROP was shown to be GPVI- and partly CLEC-2-triggered since blockade or loss of these receptors markedly deteriorated ROP progression.
Proplatelet formation from MKs is highly dependent on a functional microtubule and actin cytoskeleton, the latter of which is regulated by several actin-monomer binding proteins including Cofilin1 and Twinfilin1 that have been associated with actin-severing at pointed ends. In the present study, a redundancy between both proteins especially important for the guided release of proplatelets into the bloodstream was identified, since deficiency in both proteins markedly impaired MK functionality mainly due to altered actin-microtubule crosstalk.
Besides ITAM-triggered activation, platelets and MKs are dependent on inhibitory receptors, which prevent overshooting activation. We here identified macrothrombocytopenic mice with a mutation within Mpig6b encoding the ITIM-bearing receptor G6b-B. G6b-B-mutant mice developed a severe myelofibrosis associated with sex-specific bone remodeling defects resulting in osteosclerosis and -porosis in female mice. Moreover, G6b-B was shown to be indispensable for MK maturation as verified by a significant reduction in MK-specific gene expression in G6b-B-mutant MKs due to reduced GATA-1 activity.
Summary
Bees, like many other organisms, evolved an endogenous circadian clock, which enables them to foresee daily environmental changes and exactly time foraging flights to periods of floral resource availability. The social lifestyle of a honey bee colony has been shown to influence circadian behavior in nurse bees, which do not exhibit rhythmic behavior when they are nursing. On the other hand, forager bees display strong circadian rhythms. Solitary bees, like the mason bee, do not nurse their offspring and do not live in hive communities, but face the same daily environmental changes as honey bees. Besides their lifestyle mason and honey bees differ in their development and life history, because mason bees overwinter after eclosion as adults in their cocoons until they emerge in spring. Honey bees do not undergo diapause and have a relatively short development of a few weeks until they emerge. In my thesis, I present a comparison of the circadian clock of social honey bees (Apis mellifera) and solitary mason bees (Osmia bicornis and Osmia cornuta) on the neuroanatomical level and behavioral output level.
I firstly characterized in detail the localization of the circadian clock in the bee brain via the expression pattern of two clock components, namely the clock protein PERIOD (PER) and the neuropeptide Pigment Dispersing Factor (PDF), in the brain of honey bee and mason bee. PER is localized in lateral neuron clusters (which we called lateral neurons 1 and 2: LN1 and LN2) and dorsal neuron clusters (we called dorsal lateral neurons and dorsal neurons: DLN, DN), many glia cells and photoreceptor cells. This expression pattern is similar to the one in other insect species and indicates a common ground plan of clock cells among insects. In the LN2 neuron cluster with cell bodies located in the lateral brain, PER is co-expressed with PDF. These cells build a complex arborization network throughout the brain and provide the perfect structure to convey time information to brain centers, where complex behavior, e.g. sun-compass orientation and time memory, is controlled. The PDF arborizations centralize in a dense network (we named it anterio-lobular PDF hub: ALO) which is located in front of the lobula. In other insects, this fiber center is associated with the medulla (accessory medulla: AME). Few PDF cells build the ALO already in very early larval development and the cell number and complexity of the network grows throughout honey bee development. Thereby, dorsal regions are innervated first by PDF fibers and, in late larval development, the fibers grow laterally to the optic lobe and central brain. The overall expression pattern of PER and PDF are similar in adult social and solitary bees, but I found a few differences in the PDF network density in the posterior protocerebrum and the lamina, which may be associated with evolution of sociality in bees.
Secondly, I monitored activity rhythms, for which I developed and established a device to monitor locomotor activity rhythms of individual honey bees with contact to a mini colony in the laboratory. This revealed new aspects of social synchronization and survival of young bees with indirect social contact to the mini colony (no trophalaxis was possible). For mason bees, I established a method to monitor emergence and locomotor activity rhythms and I could show that circadian emergence rhythms are entrainable by daily temperature cycles. Furthermore, I present the first locomotor activity rhythms of solitary bees, which show strong circadian rhythms in their behavior right after emergence. Honey bees needed several days to develop circadian locomotor rhythms in my experiments. I hypothesized that honey bees do not emerge with a fully matured circadian system in the hive, while solitary bees, without the protection of a colony, would need a fully matured circadian clock right away after emergence. Several indices in published work and preliminary studies support my hypothesis and future studies on PDF expression in different developmental stages in solitary bees may provide hard evidence.
Identification and characterization of TAT-5 interactors that regulate extracellular vesicle budding
(2021)
Cells from bacteria to man release extracellular vesicles (EV) such as microvesicles (MV) that carry signaling molecules like morphogens and miRNAs to control intercellular communication during health and disease. MV release also sculpts membranes, e.g. repairing damaged membranes to avoid cell death. HIV viruses also bud from the plasma membrane in a similar fashion. In order to determine the in vivo functions of MVs and regulate their release, we need to understand the mechanisms of MV release by plasma membrane budding (ectocytosis).
The conserved phospholipid flippase TAT-5 maintains the asymmetric localization of phosphatidylethanolamine (PE) in the plasma membrane and was the only known inhibitor of ESCRT-mediated ectocytosis in C. elegans. Loss of TAT-5 lipid flipping activity increased the externalization of PE and accumulation of MVs. However, it was unclear how cells control TAT-5 activity to release the right amount of MVs at the right time, since no upstream regulators of TAT-5 were known.
To identify conserved TAT-5 regulators we looked for new proteins that inhibit MV release. To do so, we first developed a degradation-based technique to specifically label MVs. We tagged a plasma membrane reporter with the endogenous ZF1 degradation tag (degron) and expressed it in C. elegans embryos. This reporter is protected from degradation inside MVs, but is degraded inside the cell. Thus, the fluorescence is selectively maintained inside MVs, creating the first MV-specific reporter. We identified four MV release inhibitors associated with retrograde recycling, including the class III PI3Kinase VPS-34, Beclin1 homolog BEC-1, DnaJ protein RME-8, and the uncharacterized Dopey homolog PAD-1. We found that VPS-34, BEC-1, RME-8, and redundant sorting nexins are required for the plasma membrane localization of TAT-5, which is important to maintain PE asymmetry and inhibit MV release. Although we confirmed that PAD-1 and the GEF-like protein MON-2 are required for endosomal recycling, they only traffic TAT-5 in the absence of sorting nexin-mediated recycling. Instead, PAD-1 is specifically required for the lipid flipping activity of TAT-5 that inhibits MV release.
Thus, our work pinpoints TAT-5 and PE as key regulators of plasma membrane budding, further supporting the model that PE externalization drives ectocytosis. In addition, we uncovered redundant intracellular trafficking pathways, which affect organelle size and revealed new regulators of TAT-5 flippase activity. These newly identified ectocytosis inhibitors provide a toolkit to test the in vivo roles of MVs. In the long term, our work will help to identify the mechanisms that govern MV budding, furthering our understanding of the mechanisms that regulate disease-mediated EV release, membrane sculpting and viral budding.
Arid environments cover almost one-third of the land over the world. Plant life in hot arid regions is prone to the water shortage and associated high temperatures. Drought-stressed plants close the stomata to reduce water loss. Under such conditions, the remaining water loss exclusively happens across the plant cuticle. The cuticular water permeability equals the minimum and inevitable water loss from the epidermal cells to the atmosphere under maximally stomatal closure. Thus, low cuticular water permeability is primordial for plant survival and viability under limited water source. The assumption that non-succulent xerophytes retard water loss due to the secretion of a heavier cuticle is often found in the literature. Intuitively, this seems to be plausible, but few studies have been conducted to evaluate the cuticular permeability of xerophilous plants. In chapter one, we investigated whether the cuticular permeability of Quercus coccifera L. grown in the aridest Mediterranean-subtype climate is indeed lower than that of individuals grown under temperate climate conditions. Also, the cuticular wax chemical compositions of plants grown in both habitats were qualitatively and quantitatively analysed by gas-chromatography. In few words, our findings showed that although the cuticular wax deposition increased in plants under Mediterranean climate, the cuticular permeability remained unaltered, regardless of habitat.
The associated high temperatures in arid regions can drastically increase the cuticular water permeability. Thereby, the thermal stability of the cuticular transpirational barrier is decisive for safeguarding non-succulent xerophytes against desiccation. The successful adaptation of plants to hot deserts might be based on finding different solutions to cope with water and heat stresses. Water-saver plants close the stomata before the leaf water potential drastically changes in order to prevent damage, whereas water-spender plants reduce the leaf water potential by opening the stomata, which allow them to extract water from the deep soil to compensate the high water loss by stomatal transpiration. In chapter two, we compare the thermal stability of the cuticular transpiration barrier of the desert water-saver Phoenix dactylifera L. and the water-spender Citrullus colocynthis (L.) Schrad. In short, the temperature-dependent increase of the cuticular permeability of P. dactylifera was linear over the whole temperature range (25-50°C), while that of C. colocynthis was biphasic with a steep increase at temperatures ≥ 40°C. This drastic increase of cuticular permeability indicates a thermally induced breakdown of the C. colocynthis cuticular transpiration barrier, which does not occur in P. dactylifera. We further discussed how the specific chemical composition of the cutin and cuticular waxes might contribute to the pronounced thermal resistance of the P. dactylifera cuticular transpiration barrier.
A multitude of morpho and physiological modifications, including photosynthetic thermal tolerance and traits related to water balance, led to the successful plant colonisation of hot arid regions over the globe. High evaporative demand and elevated temperatures very often go along together, thereby constraining the plant life in arid environments. In chapter 3, we surveyed cuticular permeability, leaf thermal tolerance, and cuticular wax chemical composition of 14 non-succulent plant species native from some of the hottest and driest biomes in South-America, Europe, and Asia. Our findings showed that xerophilous flowering plants present high variability for cuticular permeability and leaf thermal tolerance, but both physiological features could not be associated with the species original habitat. We also provide substantial evidence that non-succulent xerophytes with more efficient cuticular transpirational barrier have higher leaf thermal tolerance, which might indicate a potential coevolution of these features in hot arid biomes. We further discussed the efficiency of the cuticular transpiration barrier in function to the cuticular wax chemical composition in the general discussion section.
Peptide receptor radionuclide therapy (PRRT) is a molecular targeted radiation therapy involving the systemic administration of radiolabeled somatostatin receptor binding peptides designed to target with high affinity and specificity receptors overexpressed on tumors. Peptides are applied which either target as agonist (with internalization) or antagonist (little to no internalization). Recently, two novel antagonistic agents have been developed for clinical use: OPS202 and OPS201. 68Ga-labelled OPS202 is used for diagnostic purposes with positron emission tomography and 177Lu-labelled OPS201 is used for the therapy in patients with neuroendocrine tumors (NETs). Both agents are presently under clinical evaluation. Despite the very low internalization rate, the use of somatostatin receptor antagonists which target more binding sites on receptors are expected to result in higher specificity, more favorable pharmacokinetics and higher tumor retention and better visualization than the agonists. The main goal of this thesis was analyzing the biodistribution, biokinetics and internal dosimetry of the recently developed somatostatin receptor antagonists (OPS201 and OPS202) for therapeutic and diagnostic purposes in different species (mice, pigs and patients). In addition, an analysis of the influence of image quantification and the integration of time activity curves on kidney dosimetry in a pig model was carried out. Furthermore, extrapolation methods, which are used for predicting organ absorbed doses for humans based on preclinical animal models, were systematically compared for blood, liver, and kidneys of OPS201 injected species. Based on the OPS202 injected patients’ investigations, 68Ga-OPS202 shows promising biodistribution and imaging properties with tumor contrast which is optimal one hour after injection of the radiotracer. OPS202 is well tolerated and delivers absorbed doses to organs that are lower than those by 18F-FDG and similar to other 68Ga-labeled somatostatin receptor ligands. As a result of 68Ga OPS202 injection, the highest absorbed doses were observed in the urinary bladder (0.10 mGy/MBq) and kidneys (0.84 mGy/MBq). The calculated mean effective dose coefficient of 68Ga-OPS202 injected patients was 0.024 mSv/MBq (3.6 mSv for 150 MBq 68Ga-OPS202 injection) which is similar to other 68Ga-labeled compounds. Based on the OPS201 biokinetics and dosimetry investigations, after the injection of 177Lu-OPS201, a fast blood clearance of the compound is observed in the first phase (half-life: 1.83 h) for each species. 10 min after injection, less than 5% of the injected activity per milliliter of blood circulates in pigs and humans. The analysis of the mice, pig and preliminary patient data provides evidence that, patients enrolled in a phase 1 177Lu-OPS201 trial would not be at risk of overexposure. Based on our results, for 177Lu labelled studies, late time points after 72 h have a great impact on absorbed dose calculations. That is why follow-up times especially at late time points (more than 72 h) are required for the time-integrated activity coefficient (TIAC) calculations in order to represent the area under the curve appropriately and to analyze both biokinetics and dosimetry accurately. In addition, to find the most adequate extrapolation methods that minimize the interspecies differences of dosimetry data, several extrapolation methods from animal to human have been tested. For OPS201 time scaling or combination of relative mass and time scaling results in most similar TIAC values, if the organ mass ratios between the species are high. In time scaling, the scan/sampling time is scaled by using the ratio of the whole body masses of the respective species. In relative mass scaling, the TIACs are scaled based on the ratio of the whole body and organ mass of respective species. Other methods tested showed higher deviations. For the study on the influence of image quantification and the choice of the optimal scanning time points, a study in a pig model, which was performed in collaboration with Aalborg University and Octreopharm Sciences GmbH, was reanalyzed. As kidneys are organs-at-risk in PRRT with 177Lu labelled peptides, several quantification methods, based on 2D and 3D quantitative imaging were chosen. For this purpose, a 3D printed pig kidney phantom was prepared and measured with/without background activities representing the activities in the pig SPECT/CT scans. The phantom dosimetry data based on multiple SPECT/CT images and based on multiple planar images in combination with one SPECT/CT scan (MP1S Imaging) were compared to the pig dosimetry. The calculated TIACs of the phantom with background based on multiple SPECT/CT and MP1S imaging were quite similar to the multiple SPECT/CT based pig TIAC. In addition, in order to investigate the effect of late time points on dosimetry and absorbed dose values in 177Lu therapies, the difference, associated with eliminating the late two scan time points, on the TIACs was analyzed. When the TIACs (including all time points) of the pig based on multiple SPECT/CT and MP1S imaging were investigated, the use of MP1S imaging results in considerably lower TIAC values to the kidney (by a factor of 1.4). With eliminating late time points from the created time activity curve, the factor increases up to 2.4 times with a corresponding increase in TIAC uncertainties. As a consequence, further evaluation of 68Ga-OPS202 for PET/CT imaging and 177Lu-OPS201 for the treatments of NET patients is necessary. In particular, a head-to-head comparison of agonists and OPS peptides with respect to biokinetics, biodistribution and dosimetry would be helpful. In addition, the influence of the late scan time points on dosimetry needs further attention in particular for kidney dosimetry
Bevor ein zellbasiertes GTMP erstmalig beim Menschen angewendet werden kann, müssen verschiedene notwendige nicht-klinische Studien durchgeführt werden. Wichtig ist hier u.a. die Untersuchung der Biodistribution im Tiermodel. Diese umfasst die Verteilung, das Engraftment, die Persistenz, die Eliminierung und gegebenenfalls die Expansion der humanen Zellen in verschiedenen Organen, meistens im Mausmodel. Deshalb wurde eine qPCR-basierte Analysenmethode entwickelt, mit der humane genomische DNA innerhalb von muriner genomischer DNA bestimmt werden kann, und entsprechend den regulatorischen Richtlinien der European Medicines Agency und des International Council for Harmonisation validiert. Anschließend wurde diese Methode innerhalb einer präklinischen worst-case Szenario Biodistributionsstudie angewendet. Das Ziel dieser Studie war die Untersuchung des Biodistributionsprofils von genetisch modifizierten Blood Outgrowth Endothelial Cells von Hämophilie A Patienten 24 Stunden und sieben Tage nach intravenöser Applikation einer Dosis von 2x106 Zellen. Die Isolation, genetische Modifikation und die Expansion der Zellen sollte entsprechend den Richtlinien der Guten Herstellungspraxis durchgeführt werden. Hierbei ist die Auswahl und Anwendung geeigneter und essentieller Rohstoffe wichtig. Gleichermaßen ist die Durchführung einer definierten Qualitätskontrollstrategie notwendig und die Patientenzellen sollten nur innerhalb von nicht-klinischen Studien eingesetzt werden, wenn alle Akzeptanzkriterien erfüllt wurden. Die Validierung der qPCR-Methode zeigte eine hohe Genauigkeit, Präzision und Linearität innerhalb des Konzentrationsintervalls von 1:1x103 bis 1:1x106 humanen zu murinen Genomen. Bei Anwendung dieser Methode für die Biodistributionsstudie konnten nach 24 Stunden humane Genome in vier der acht untersuchten Mausorgane bestimmt werden. Nach sieben Tagen konnten in keinem der acht Organe humane Genome nachgewiesen werden...
Die Entwicklung des Schädeldachs beginnt beim Menschen bereits in der frühen Embryogenese und ist erst im Erwachsenenalter abgeschlossen. Das Wachstum der Schädelknochen muss sich während der Entwicklung fortwährend dem Gehirnwachstum anpassen. An den Stellen, wo zwei Schädelknochen aufeinandertreffen, formen sich Schädelnähte, die aus mesenchymalem Bindegewebe bestehen und als Wachstumsfugen des Schädels dienen. Tritt eine frühzeitige Verknöcherung innerhalb einer oder mehrerer Schädelnähte auf, spricht man von einer Kraniosynostose. Als Konsequenz wird ein weiteres Knochenwachstum verhindert, sodass sich das Neurokranium in dieser Region nicht dem expansiven Wachstum des Gehirns anpassen kann. Dies geht in der Regel mit einem kompensatorischen Wachstum des Schädels und infolgedessen mit kraniofazialen Dysmorphien und einem erhöhten intrakraniellen Druck einher. Klinische Studien und Forschungen an Modellorganismen konnten bereits eine Vielzahl an Genen mit der Entstehung von Kraniosynostosen assoziieren, darunter die Transkriptionsfaktoren TCF12 und TWIST1. Beim Menschen sind heterozygote Mutationen in TCF12 und TWIST1 mit Kraniosynostosen der Koronarnaht assoziiert. Bei Mäusen hingegen führt eine heterozygote Tcf12 Mutation nur in Kombination mit einer heterozygoten Twist1 Mutation zu Fusionen der Koronarnaht.
Der Zebrabärbling (Danio rerio, überwiegend auch Zebrafisch genannt) weist eine bemerkenswerte Ähnlichkeit bezüglich der Anatomie und Morphologie des Schädeldachs zum Menschen auf. Um die genaue Funktion von TCF12 bei der Ausbildung der Schädelnähte zu untersuchen, wurde im Rahmen dieser Arbeit der Zebrafisch als in vivo Modell für die Entstehung tcf12-induzierter Kraniosynostosen etabliert. Zu Beginn der Arbeit wurde das Expressionsmuster von tcf12 über die Entwicklung hinweg analysiert. Ein besonderer Fokus lag dabei auf einem Expressionsnachweis während der Entwicklung der Schädelplatten und der Schädelnähte. Ein erster Expressionsnachweis von tcf12 mittels PCR-Analysen und Whole-mount RNA in-situ Hybridisierungen zeigte eine breite Expression von tcf12 ab dem 1-3 Somiten Stadium an. Für tiefergehende in vivo Analysen wurden im Zuge dieser Arbeit tcf12:EGFP Reportergenlinien generiert. Mit diesen gelang ein Nachweis der tcf12 Expression entlang der Wachstumsfronten der Schädelplatten, innerhalb der Schädelnähte sowie im Periost und der Dura mater.
Mit den tcf12:EGFP Fischen als Referenz wurde in weiterführenden Experimenten die Aktivität drei hochkonservierter CNEs (engl. conserved non-coding elements) in vivo im Zebrafisch untersucht. Zwei der CNEs konnten als tcf12 Enhancer verifiziert werden, die eine Genexpression während der Neurogenese des zentralen Nervensystems (ZNS) steuern. Die beiden Enhancer-Elemente zeichnen sich durch eine hohe Konservierung vom Menschen bis hin zum Zebrafisch aus.
Aufgrund der unterschiedlichen Sensitivität gegenüber einem Funktionsverlust von TCF12 und TWIST1 in Mensch und Maus sollte die Auswirkung eines Knockouts der orthologen Gene auf die Entwicklung der Schädelnähte des Zebrafisches untersucht werden. Mittels CRISPR/Cas9 wurden verschiedene Knockout-Linien für die Gene tcf12, twist1a und twist1b generiert. Analysen der Knockoutmutanten zeigten, dass ein heterozygoter Verlust von tcf12 und twist1b in seltenen Fällen zu partiellen Fusionen der Koronarnähte im Zebrafisch führt. Des Weiteren konnte bei tcf12 und twist1b Einzel- und Doppelmutanten ein abnormes Wachstum der Schädelplatten im Bereich der Suturen beobachtet werden. Die Expressionsstudien und die Analysen der Knockoutmutanten deuten auf eine Regulation von TCF12 bei der Differenzierung der Stammzellen sowie der Proliferation der Osteoblasten innerhalb der Schädelnähte hin.
Um die Auswirkung von TCF12 Mutationen auf funktioneller Ebene zu untersuchen wurden im Verlauf dieser Arbeit Luciferase-Reporter Assays durchgeführt. Anhand dieser konnte nachgewiesen werden, dass Mutationen, die die basic helix-loop-helix (bHLH)-Domäne beeinträchtigen, die Transaktivierungsfähigkeit von TCF12 aufheben. Co-Transfektions-Experimente mit TWIST1 offenbarten eine Regulation der Transaktivierung von TCF12 durch TWIST1, sowohl im Menschen, als auch im Zebrafisch. Im Rahmen dieser Arbeit konnten die genauen Expressionsorte von TCF12 während der Morphogenese des Schädeldachs nachgwiesen und die Funktion von TCF12 und seinem Interaktionspartner TWIST1 bei der Entstehung von Kraniosynostosen weiter aufgeklärt werden.
Die AAA+ ATPase p97 ist ein essenzielles Protein, das an einer Vielzahl zellulärer Prozesse beteiligt ist und eine Schlüsselrolle in der Protein-Homöostase spielt. Die funktionale Diversität von p97 beruht auf der Interaktion zahlreicher unterschiedlicher Kofaktoren, die vorwiegend an die N-Domäne von p97 binden. Aufgrund seiner Bedeutung in der Regulierung diverser physiologischer und pathologischer Prozesse stellt p97 eine interessante Zielstruktur für die Entwicklung neuer Wirkstoffe dar, die insbesondere in der Krebstherapie von Bedeutung sein könnte. Bekannte p97-Inhibitoren greifen vor allem die ATPase-Funktion des Proteins an. Ein neuer pharmakologischer Ansatz stellt die Inhibierung der Kofaktorbindung an die N-Domäne dar. Ein solcher Protein-Protein-Interaktionsinhibitor wäre nicht nur von therapeutischem Interesse, sondern hätte auch einen besonderen Nutzen für die Entschlüsselung molekularer und zellulärer Funktionen von p97-Kofaktoren. In dieser Arbeit wurde ein fragmentbasierter Ansatz für die Identifizierung von chemischen Startstrukturen für die Entwicklung eines Protein-Protein- Interaktionsinhibitors verfolgt. Als Zielstruktur wurde die SHP-Bindestelle in der N-Domäne gewählt. Die Identifizierung von Liganden erfolgte sowohl durch computergestützte Methoden (insbesondere virtuelles Screening und Molekulardynamik-Simulationen) als auch experimentell durch biophysikalische Techniken (wie Biolayer-Interferometrie, Röntgenstrukturanalyse und ligandbasierte NMR-Techniken). Die Grundlage des computerbasierten Designs stellte eine Analyse der bekannten Kristallstrukturen der p97-Komplexe mit den SHP-Motiven der Kofaktoren UFD1 und Derlin-1 dar. Darüber hinaus dienten Molekulardynamik-Simulationen der Analyse der Wassereigenschaften innerhalb der SHP-Bindestelle. Darauf aufbauend wurden verschiedene Pharmakophormodelle entwickelt, die die Grundlage des im Anschluss durchgeführten virtuellen Screenings und Dockings bildeten. Anhand der Ergebnisse von Molekulardynamik-Simulationen wurden zehn Verbindungen für die experimentelle Validierung ausgewählt. Hiervon konnten zwei Fragmente in STD-NMR- und Biolayer-Interferometrie-Experimenten als Liganden bestätigt werden. In einem parallel durchgeführten biophysikalischen Fragmentscreening mittels Biolayer-Interferometrie wurden unter mehr als 650 Verbindungen 22 identifiziert, die an die N-Domäne binden. 15 dieser Fragmente wurden durch einen orthogonalen STD-NMR-Assay bestätigt. Fünf dieser Verbindungen zeigten Affinitäten mit KD-Werten kleiner 500μMund günstigen Ligandeffizienzen. Des Weiteren konnte die Bindungskinetik und Affinität des in der Literatur als p97-Inhibitor berichteten Naturstoffes Xanthohumol bestimmt und eine Bindung an die N-Domäne bestätigt werden. Zur Identifizierung möglicher Bindestellen dieser fünf Fragmente wurden mixed-solvent Molekulardynamik-Simulationen durchgeführt. Diese ergaben, dass alle Verbindungen die SHP-Bindestelle in der N-Domäne adressieren. Die Regionen fielen mit hot spots der Kofaktorwechselwirkungen zusammen und stellen somit mögliche Ankerpunkte für die Weiterentwicklung dar. Für zwei Fragmente konnten die postulierten Bindestellen mittels Röntgenstrukturanalyse bzw. STD-NMR-Messungen an p97-Alanin-Mutanten bestätigt werden. Die erhaltene Röntgenstruktur ist die erste p97-Struktur, die ein gebundenes Fragment an der N-Domäne zeigt.
Background: In recent years, health care has increasingly become the focus of public interest, politics, health insurance companies, and research. This includes the development of therapeutic concepts that can respond individually to patients' resources in order to improve coping with chronic diseases. Research into psychosocial and biological resilience factors is very important and the basic objective of the present work. I studied patients with fibromyalgia syndrome (FMS), who suffer among others from chronic pain, fatigue, sleep and gastrointestinal problems. This patient cohort is characterized by a pronounced heterogeneity in terms of clinical outcome, degree in disability and coping. FMS has a prevalence of 3 – 8 % in the Western population and has a significant socio-economic impact. Validated psychosocial resilience factors include optimism, humor, coherence, self-efficacy, awareness with one's own resources and the ability to apply them profitably (coping), and a healthy social environment with positive relationships. Studies in patients with cancer revealed religiosity as positive and negative factor on the health outcome, but there is little data on religious aspects of pain resilience. Various genetic polymorphisms and anti-inflammatory cytokines are known as biological resilience factors. Various microRNA (miRNA) were detected to contribute to resilience in the context of stress and psychiatric disorders. Objective: The underlying research question of this work is to understand the factors that make some FMS patients resilient and others not, even though they suffer from the same disease. The long-term aim was to understand mechanisms and influencing factors of resilience to design preventive and resource-oriented therapies for FMS patients. Material and Methods: Three studies examined religious, physiological, biological, and psychosocial factors which may contribute to resilience in FMS patients. Study one combined data of questionnaires, a psychosocial interview, and regression analyses to investigate the relevance of religiosity for coping and resilience. Study two examined variance explaining factors and defined clusters among FMS patients by their differences in coping, pain phenotype and disability. The factor analysis used variables derived from questionnaires and qPCR of cytokines in white blood samples (WBC) of patients and healthy controls. Study three assessed cluster-wise miRNA signatures which may underly differences in behaviour, emotional and physiological disability, and resilience among patient clusters. A cluster-specific speculative model of a miRNA-mediated regulatory cycle was proposed and its potential targets verified by an online tool. Results: The data from the first study revealed a not very religious patient cohort, which was rather ambivalent towards the institution church, but described itself as a believer. The degree of religiosity played a role in the choice of coping strategy but had no effect on psychological parameters or health outcomes. The coping strategy "reinterpretation", which is closely related iv to the religious coping "reappraisal", had the highest influence on FMS related disability. Cognitive active coping strategies such as reappraisal which belongs to religious coping had the highest effect on FMS related disability (resilience) and could be trained by a therapist. Results from the second study showed high variances of all measured cytokines within the patient group and no difference between patient and control group. The high dispersion indicated cluster among patients. Factor analysis extracted four variance-explaining factors named as affective load, coping, pain, and pro-inflammatory cytokines. Psychological factors such as depression were the most decisive factors of everyday stress in life and represented the greatest influence on the variance of the data. Study two identified four clusters with respective differences in the factors and characterized them as poorly adapted (maladaptive), well adapted (adaptive), vulnerable and resilient. Their naming was based on characteristics of both resilience concepts, indicated by patients who were less stress-sensitive and impaired as a personal characteristic and by patients who emerged as more resilient from a learning and adaptive process. The data from the variance analysis suggests that problem- and emotion-focused coping strategies and a more anti-inflammatory cytokine pattern are associated with low impairment and contribute to resilience. Additional favorable factors include low anxiety, acceptance, and persistence. Some cluster-specific intervention proposals were created that combine existing concepts of behavioral and mindfulness therapies with alternative therapies such as vitamin D supplementation and a healthy intestinal flora. The results of the third study revealed lower relative gene expression of miR103a-3p, miR107, and miR130a-3p in the FMS cohort compared to the healthy controls with a large effect size. The adaptive cluster had the highest gene expression of miR103a-3p and tendentially of miR107, which was correlated with the subscale score "physical abuse" of the trauma questionnaire. Further correlations were found in particular with pain catastrophizing and FMS-related disability. MiR103a-3p and miR107 form a miRNA-family. Based on this, we proposed a miR103a/107 regulated model of an adaptive process to stress, inflammation and pain by targeting genetic factors which are included in different anti-inflammatory and stress-regulating pathways. Conclusion: All three studies provide new insights into resilience in FMS patients. Cognitive coping (reappraisal/reinterpretation) plays a central role and thus offers therapeutic targets (reframing in the context of behavioral therapy). Religosity as a resilience factor was only partially valid for our patient cohort. Basically, the use of resource-oriented therapy in large institutions still requires research and interdisciplinary cooperation to create a consensus between the humanities, natural sciences and humanism.
In dieser Arbeit wurde untersucht, ob eine anodale tDCS über der Elektrodenposition AF3 und der Kathode über dem kontralateralen Mastoid Extinktionslernen modulieren kann. Auf Basis aktueller Forschungsergebnisse wurden die Hypothesen aufgestellt, dass im Vergleich von real stimulierter zu sham stimulierter Gruppe ein Unterschied in der Hautleitfähigkeitsrekation, dem Arousalrating und dem Valenzrating der Versuchsteilnehmenden im Vergleich von CS+ und CS- und im zeitlichen Verlauf von Akquisition zu Extinktion gezeigt werden kann. Um dies zu prüfen wurde eine randomisiert doppelt-verblindete Studie mit insgesamt 86 Probanden durchgeführt, von denen nach Überprüfen einer suffizienten Furchtkonditionierungsreaktion nach der Akquisitionsphase noch 46 Teilnehmer eingeschlossen wurden. Diese wurden auf zwei tDCS Gruppen im Sinne von realer Stimulation und sham Stimulation verblindet und zufällig aufgeteilt. Alle Teilnehmer durchliefen ein eintägiges Furchtkonditionierungsparadigma mit drei Phasen: Habituation, Akquisition und Extinktion. Während allen Phasen wurde die Hautleitfähigkeitsreaktion gemessen und die Probanden wurden gebeten die ihnen präsentierten Stimuli hinsichtlich deren Valenz und Arousal einzuschätzen. Die tDCS fand in einer zehnminütigen Pause vor der Extinktion und während destdcs
Extinktionsdurchlaufs statt. In den Ergebnissen zeigt sich kein differenzieller Effekt der tDCS. In den erhobenen Hautleitfähigkeitsdaten zeigt sich in der frühen Extinktionsphase eine verringerte Hautleitfähigkeit in der verum stimulierten tDCS Gruppe unabhängig davon, ob ein CS+ oder ein CS- zu sehen war. Dies deutet auf eine generell verminderte Aufregung bei realer tDCS hin. In den Bewertungen bezüglich Arousal und Valenz findet sich ebenfalls kein Effekt der tDCS. In den Bewertungen zeigt sich jedoch die erfolgreiche Konditionierung und deren Extinktion. Nachfolgend stellt sich die Frage, ob zukünftig Paradigmen mit einem zweitägigen Design bevorzugt werden sollten, da diese realen Bedingungen näherkommen und teilweise auch Effekte der tDCS gezeigt haben. Abschließend lässt sich die große Rolle des vmPFC in der Verarbeitung von aversiven Reizen darstellen und betonen, welch großes Potential in einer Beeinflussung der Aktivität des vmPFC liegt, das zukünftig genauer untersucht werden muss.
Introduction: Abdominal aortic aneurysm (AAA) is a pathological saccular enlargement most often of the infrarenal aorta. Eventual rupture is fatal, making preemptive surgical therapy upon a diameter threshold of >50mm the treatment of choice. The pathophysiology, especially the initial trigger aortic remodeling is still largely unknown. However, some characteristic features involved in aneurysm growth have been established, such as medial angiogenesis, low-grade inflammation, vascular smooth muscle cell (VSMC) phenotype switch, extracellular remodeling, altered hemodynamics and an eventual humoral immune answer. Currently, no medical treatment options are available. RNA therapeutics and drug repurposing offer new possibilities to overcome this shortage. Using such to target angiogenesis in the aneurysm wall and investigate their potential mechanisms is the aim of this thesis. Material and Methods: We test our hypothesis by targeting the long non-coding RNA H19 and re-use the anti-cancer drug Lenvatinib in two murine inducible AAA models and one preclinical large animal model in the LDLR-/- pig. Furthermore, a H19-/- mouse is included to verify the results. AAA and control samples from a human biobank along with a primary human cell culture are used to verify results ex vivo by qPCR, WesternBlot, live cell imaging, histo- and immunohistochemistry along with gene array analysis, RNA knockdown, pull-down- and promotor assays. Results: H19 is significantly upregulated in AAA mice models and its knockdown limited aneurysm growth. It is well known that H19 interacts with several transcription factors. We found that cytoplasmic interaction between H19 and hypoxia-inducible factor 1-alpha (HIF1α) increased apoptosis in cultured SMCs associated with sequential p53 stabilization. In contrast, the knockdown of H19 was associated with markedly decreased apoptotic cell rates. Our data underline that HIF1α was essential in mediating the pro-apoptotic effects of H19. Secondly, Lenvatinib was applied both systemically and locally by endovascular means in mice with an established AAA. The drug significantly halted aneurysm growth and array analysis revealed myosin heavy chain 11 (MYH11) as the most differentially regulated target. This was shown to be up regulated after Lenvatinib treatment of primary AAA smooth muscle cells suggesting a salvage mechanism to obtain a contractile phenotype based on gene expression and immunohistochemistry. The same results were shown upon a local endovascular Lenvatinib-coated balloon angioplasty in the established aneurysmatic lesion of a novel atherosclerotic LDLR-/- Yucatan minipig model. Decreased phosphorylation of extracellular-signal regulated kinases 1-2 (ERK1-2) is the downstream effect of Lenvatinib-specific blockage of the vascular endothelial growth factor receptor (VEGFR2). Conclusion: Taking into account the heterogeneity of the disease, inhibition of VSMC phenotype switch, extracellular remodeling and angiogenesis seem promising targets in some if not all AAA patients. Together with surveillance and surgical therapy, these new non-invasive treatment strategies would allow for a more personalized approach to treat this disease.